CoChat

Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study

Lin, Bochao D, Alkema, Anne, Peters, Triinu, Zinkstok, Janneke, Libuda, Lars, Hebebrand, Johannes, Antel, Jochen, Hinney, Anke, Cahn, Wiepke, Adan, Roger, Luykx, Jurjen J · 2019 · International Journal of Epidemiology
Cited by 58

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

Background: Blood immunoreactive biomarkers, such as C-reactive protein (CRP), and metabolic abnormalities have been associated with schizophrenia. Studies comprehensively and bidirectionally probing possible causal links between such blood constituents and liability to schizophrenia are lacking. Methods: To disentangle putative causal links between CRP blood levels and schizophrenia in both directions, we conducted multiple univariable Mendelian-randomization (MR) analyses, ranging from fixed-effect to inverse variance-weighted (IVW), weighted-median, MR Egger and generalized summary-data-based Mendelian-randomization (GSMR) models. To prioritize metabolic risk factors for schizophrenia, a novel multivariable approach was applied: multivariable Mendelian-randomization–Bayesian model averaging (MR-BMA). Results: All forward univariable MR analyses consistently showed that CRP has a protective effect on schizophrenia, whereas reverse MR analyses consistently suggested absent causal effects of schizophrenia liability on CRP blood levels. Using MR-BMA, as the top protective factors for schizophrenia we prioritized leucine and as the prime risk-factor triglycerides in medium very-low-density lipoprotein (VLDL). The five best-performing MR-BMA models provided one additional risk factor: triglycerides in large VLDL; and two additional protective factors: citrate and lactate. Conclusions: Our results add to a growing body of literature hinting at metabolic changes—in particular of triglycerides—independently of medication status in schizophrenia. We also highlight the absent effects of genetic liability to schizophrenia on CRP levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ije/dyz176

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 34

  1. Miller, 2014, C-reactive protein levels in schizophrenia: a review and meta-analysis, Clin Schizophr Relat Psychoses, 7, 223, 10.3371/CSRP.MICU.020813 · DOI · Paper page
  2. Gonzalez-Blanco, 2018, Elevated C-reactive protein as a predictor of a random one-year clinical course in the first ten years of schizophrenia, Psychiatry Res, 269, 688, 10.1016/j.psychres.2018.08.042 · DOI
  3. Fond, 2018, C-Reactive protein as a peripheral biomarker in schizophrenia: an updated systematic review, Front Psychiatry, 9, 392, 10.3389/fpsyt.2018.00392 · DOI
  4. Hartwig, 2017, Inflammatory biomarkers and risk of schizophrenia: a 2-sample Mendelian randomization study, JAMA Psychiatry, 74, 1226, 10.1001/jamapsychiatry.2017.3191 · DOI · Paper page
  5. Cordes, 2017, Prevalence of metabolic syndrome in female and male patients at risk of psychosis, Schizophr Res, 181, 38, 10.1016/j.schres.2016.09.012 · DOI
  6. Ryan, 2003, Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia, Am J Psychiatry, 160, 284, 10.1176/appi.ajp.160.2.284 · DOI · Paper page
  7. Chen, 2016, Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits, Psychol Med, 46, 3219, 10.1017/S0033291716001902 · DOI
  8. Spelman, 2007, Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia, Diabet Med, 24, 481, 10.1111/j.1464-5491.2007.02092.x · DOI · Paper page
  9. Thakore, 2002, Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia, Int J Obes Relat Metab Disord, 26, 137, 10.1038/sj.ijo.0801840 · DOI · Paper page
  10. Guest, 2010, Increased levels of circulating insulin-related peptides in first-onset, antipsychotic naive schizophrenia patients, Mol Psychiatry, 15, 118, 10.1038/mp.2009.81 · DOI
  11. van Beveren, 2014, Evidence for disturbed insulin and growth hormone signaling as potential risk factors in the development of schizophrenia, Transl Psychiatry, 4, e430, 10.1038/tp.2014.52 · DOI
  12. Suhre, 2012, Genetic variation in metabolic phenotypes: study designs and applications, Nat Rev Genet, 13, 759, 10.1038/nrg3314 · DOI · Paper page
  13. Hebebrand, 2018, The role of genetic variation of human metabolism for BMI, mental traits and mental disorders, Mol Metab, 12, 1, 10.1016/j.molmet.2018.03.015 · DOI
  14. Zuber, 2018, Selecting causal risk factors from high-throughput experiments using multivariable Mendelian randomization, bioRxiv, 396333.
  15. Ligthart, 2018, Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders, Am J Hum Genet, 103, 691, 10.1016/j.ajhg.2018.09.009 · DOI · Paper page
  16. Bowden, 2016, Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I-2 statistic, Int J Epidemiol, 45, 1961
  17. 1979, Cook RD. Influential observations in linear-regression, J Am Stat Assoc, 74, 169, 10.1080/01621459.1979.10481634 · DOI · Paper page
  18. Hans, 2007, Shotgun Stochastic search for ‘Large p’ regression, J Am Stat Assoc, 102, 507, 10.1198/016214507000000121 · DOI · Paper page
  19. Yavorska, 2017, Mendelian randomization: an R package for performing Mendelian randomization analyses using summarized data, Int J Epidemiol, 46, 1734, 10.1093/ije/dyx034 · DOI · Paper page
  20. Orsolini, 2018, Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review, Curr Neuropharmacol, 16, 583, 10.2174/1570159X16666180119144538 · DOI · Paper page
  21. Saetre, 2007, Inflammation-related genes up-regulated in schizophrenia brains, BMC Psychiatry, 7, 46, 10.1186/1471-244X-7-46 · DOI · Paper page
  22. Garcia-Rizo, 2013, Inflammatory markers in antipsychotic-naive patients with nonaffective psychosis and deficit vs. nondeficit features (vol 198, pg 212, 2012), Psychiatry Res, 210, 1329., 10.1016/j.psychres.2013.08.041 · doi:10.1016/j.psychres.2013.08.041
  23. Jacomb, 2018, C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls, Front Immunol, 9, 1, 10.3389/fimmu.2018.02230 · DOI · Paper page
  24. Khandaker, 2012, Childhood infection and adult schizophrenia: a meta-analysis of population-based studies, Schizophr Res, 139, 161, 10.1016/j.schres.2012.05.023 · DOI · Paper page
  25. Benros, 2016, Influence of polygenic risk scores on the association between infections and schizophrenia, Biol Psychiatry, 80, 609, 10.1016/j.biopsych.2016.04.008 · DOI
  26. He, 2012, Schizophrenia shows a unique metabolomics signature in plasma, Transl Psychiatry, 2, e149, 10.1038/tp.2012.76 · DOI · Paper page
  27. Solberg, 2016, Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study, BMC Psychiatry, 16, 299., 10.1186/s12888-016-1006-3 · DOI · Paper page
  28. Zeynep, 2018, The relationship between serum lipid levels and lifetime suicide attempts in patients with schizophrenia, Med Sci, 7, 724
  29. Bjerkenstedt, 1987, Plasma and muscle amino-acids in relation to cerebrospinal-fluid monoamine metabolites in schizophrenic-patients and healthy controls, Int J Neurosci, 32, 707
  30. De Luca, 2008, Psychiatry Investig, 5, 203, 10.4306/pi.2008.5.4.203 · DOI
  31. Duncan, 2018, Genetic correlation profile of schizophrenia mirrors epidemiological results and suggests link between polygenic and rare variant (22q11.2) cases of schizophrenia, Schizophr Bull, 44, 1350, 10.1093/schbul/sbx174 · DOI
  32. Xuan, 2011, Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action, J Proteome Res, 10, 5433, 10.1021/pr2006796 · DOI · Paper page
  33. Matsui, 2017, Astrocytic glycogen-derived lactate fuels the brain during exhaustive exercise to maintain endurance capacity, Proc Natl Acad Sci USA, 114, 6358, 10.1073/pnas.1702739114 · DOI · Paper page
  34. Berthet, 2009, Neuroprotective role of lactate after cerebral ischemia, J Cereb Blood Flow Metab, 29, 1780, 10.1038/jcbfm.2009.97 · DOI · Paper page

Cited by

See all 58

Metadata

Authors
Lin, B. D., Alkema, A., Peters, T., Zinkstok, J., Libuda, L., Hebebrand, J., Antel, J., Hinney, A., Cahn, W., Adan, R., & Luykx, J. J.
Affiliations
  • Department of Psychiatry, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands
  • Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University of Duisburg-Essen, University Hospital Essen, Essen, Germany
  • Department of Translational Neuroscience, UMC Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands
Venue
International Journal of Epidemiology
Published
2019-08-31
Volume
48
Issue
5
Pages
1505-1514
ISSN
  • 0300-5771
  • 1464-3685
Cited by
58
References
18
Language
en
Funders
  • German Ministry for Education and Research
  • National Genome Research Net-Plus (01GS0820)
  • German Research Foundation
  • European Community's Seventh Framework Programme (245009, 262055)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.